Molecular mechanism of adaptive cytoprotection induced by ethanol in human gastric cells

Experimental Biology and Medicine

Volumn 228, Issue 9, 2003, Pages 1089-1095

  Tsutsumi, Shinji ^a   Mima, Shinji ^a   Tomisato, Wataru ^a   Hoshino, Tatsuya ^a   Tsuchiya, Tomufusa ^a   Mizushima, Tohru ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Post translational regulation; Prostaglandin E2; Protein tyrosine phosphorylation

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ACETYLSALICYLIC ACID; ALCOHOL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; TYROSINE;

ADAPTATION; ARTICLE; CELL CULTURE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROSTAGLANDIN SYNTHESIS; PROTEIN PHOSPHORYLATION; STOMACH PROTECTION; TIME SERIES ANALYSIS; TRANSLATION REGULATION;

EID: 0141640845     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020322800917     Document Type: Article

References (43)

1. Miller TA. Stress erosive gastritis: what is optimal therapy and who should undergo it? Gastroenterology 109:626-628, 1995.
2. Tomisato W, Tsutsumi S, Rokutan K, Tsuchiya T, Mizushima T. NSAIDs induce both necrosis and apoptosis in guinea pig gastric mucosal cells in primary culture. Am J Physiol Gastrointest Liver Physiol 281:G1092-G1100, 2001.
3. Tsutsumi S, Tomisato W, Takano T, Rokutan K, Tsuchiya T, Mizushima T. Gastric irritant-induced apoptosis in guinea pig gastric mucosal cells in primary culture. Biochim Biophys Acta 1589:168-180, 2002.
4. Tomisato W, Tsutsumi S, Tsuchiya T, Mizushima T. Geranylgeranylacetone protects guinea pig gastric mucosal cells from gastric stressor-induced necrosis by induction of heat-shock proteins. Biol Pharm Bull 24:887-891, 2001.
5. Vane J. Towards a better aspirin. Nature 367:215-216, 1994.
6. Jackson LM, Wu KC, Mahida YR, Jenkins D, Hawkey CJ. Cyclooxygenase (COX) I and 2 in normal. inflamed, and ulcerated human gastric mucosa. Gut 47:762-770, 2000.
7. Lim JW, Kim H, Kim KH. Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab Invest 81:349-360, 2001.
8. Mifflin RC, Saada JI, Di Mari JF, Adegboyega PA, Valentich JD, Powell DW. Regulation of COX-2 expression in human intestinal myofibroblasts: Mechanisms of IL-1-mediated induction. Am J Physiol Cell Physiol 282:C824-C834, 2002.
9. Pausawasdi N. Ramamoorthy S, Crofford LJ, Askari FK, Todisco A. Regulation and function of COX-2 gene expression in isolated gastric parietal cells. Am J Physiol Gastrointest Liver Physiol 282:G1069-G1078, 2002.
10. Parfenova H, Balabanova L, Leffler CW. Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells. Am J Physiol 274:C72-C81, 1998.
11. Robert A, Nezamis JE, Lancaster C, Davis JP, Field SO, Hanchar AJ. Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am J Physiol 245:G113-G121, 1983.
12. Kauffman GL Jr, Reeve JJ Jr., Grossman MI. Gastric bicarbonate secretion: Effect of topical and intravenous 16,16-dimethyl prostaglandin E2. Am J Physiol 239:G44-G48, 1980.
13. Keogh JP, Allen A, Garner A. Relationship between gastric mucus synthesis, secretion and surface gel erosion measured in amphibian stomach in vitro. Clin Exp Pharmacol Physiol 24:844-849, 1997.
14. Hoshino T, Takano T, Tsutsumi S, Tomisato W, Tsuchiya T, Mizushima T. Effects of prostaglandin E2 on gastric irritant-induced apoptosis. Dig Dis Sci 47:2370-2379, 2002.
15. Konturek SJ, Brzozowski T, Piastucki I, Radecki T, Dembinski A. Dembinska-Kiec A. Role of locally generated prostaglandins in adaptive gastric cytoprotection. Dig Dis Sci 27:967-971, 1982.
16. Miller TA, Henagan JM. Indomethacin decreases resistance of gastric barrier to disruption by alcohol. Dig Dis Sci 29:141-149. 1984.
17. Takeuchi K, Araki H, Umeda M, Komoike Y, Suzuki K. Adaptive gastric cytoprotection is mediated by prostaglandin EPI receptors: A study using rats and knockout mice. J Pharmacol Exp Ther 297:1160-1165, 2001.
18. Hawkey CJ, Kemp RT, Walt RP, Bhaskar NK, Davies J. Filipowicz B. Evidence that adaptive cytoprotection in rats is not mediated by prostaglandins. Gastroenterology 94:948-954, 1988.
19. Smith GS, Myers SI, Bartula LL, Miller TA. Adaptive cytoprotection against alcohol injury in the rat stomach is not due to increased prostanoid synthesis. Prostaglandins 41:207-223, 1991.
20. Ko JK, Cho CH. Co-regulation of mucosal nitric oxide and prostaglandin in gastric adaptive cytoprotection. Inflamm Res 48:471-478, 1999.
21. Cho CH, Ko JK, Tang XL. The differential mechanisms of mild irritants on adaptive cytoprotection. J Gastroenterol Hepatol 9(Suppl 1):S24-S28, 1994.
22. Nakamura K, Rokutan K, Marui N, Aoike A, Kawai K. Induction of heat shock proteins and their implication in protection against ethanol-induced damage in cultured guinea pig gastric mucosal cells. Gastroenterology 101:161-166, 1991.
23. Tepperman BL, Soper BD, Morris GP. Effect of sialoadenectomy on adaptive cytoprotection in the rat. Gastroenterology 97:123-129, 1989.
24. Kokoska ER, Smith GS, Rieckenberg CL, Deshpande Y, Banan A, Miller TA. Adaptive cytoprotection against deoxycholate-induced injury in human gastric cells in vitro: Is there a role for endogenous prostaglandins? Dig Dis Sci 43:806-815, 1998.
25. Mutoh H, Ota S, Hiraishi H, Ivey KJ, Terano A, Sugimoto T. Adaptive cytoprotection in cultured rat gastric mucus-producing cells: Role of mucus and prostaglandin synthesis. Dig Dis Sci 40:872-878, 1995.
26. Kokoska ER, Smith GS, Deshpande Y, Rieckenberg CL, Miller TA. Adaptive cytoprotection induced by ethanol in human intestinal cells: Role of prostaglandins and calcium homeostasis. Ann Surg 228:123-130, 1998.
27. Kokoska ER, Smith GS, Wolff AB, Deshpande Y, Rieckenberg CL, Banan A, Miller TA. Role of calcium in adaptive cytoprotection and cell injury induced by deoxycholate in human gastric cells. Am J Physiol 275:G322-G330, 1998.
28. Sharma SA, Tummuru MK, Miller GG, Blaser MJ. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun 63:1681-1687, 1995.
29. Nilius M, Bode G, Buchler M, Malfertheiner P. Adhesion of Helicobacter pylori and Escherichia coli to human and bovine surface mucus cells in vitro. Eur J Clin Invest 24:454-459, 1994.
30. Tsutsumi S, Tomisato W, Hoshino T, Tsuchiya T, Mizushima T. Transforming growth factor-betal is responsible for maturation-dependent spontaneous apoptosis of cultured gastric pit cells. Exp Biol Med 227:402-411, 2002.
31. Futaki N, Arai I, Hamasaka Y, Takahashi S, Higuchi S, Otomo S. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J Pharm Pharmacol 45:753-755, 1993.
32. Quinn JC, Johnson-Farley NN, Yoon J, Cowen DS. Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC 12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases. J Pharmacol Exp Ther 303:746-752, 2002.
33. Shimokawa T, Kulmacz RJ, DeWitt DL, Smith WL. Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis. J Biol Chem 265:20073-20076, 1990.
34. Guo YS, Draviam E, Townsend CM Jr., Singh P. Differential effects of Ca2+ on proliferation of stomach, colonic, and pancreatic cancer cell lines in vitro. Nutr Cancer 14:149-157, 1990.
35. Lecomte M, Laneuville O, Ji C, DeWitt DL, Smith WL. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 269:13207-13215, 1994.
36. Basque JR, Chenard M, Chailler P, Menard D. Gastric cancer cell lines as models to study human digestive functions. J Cell Biochem 81:241-251, 2001.
37. Mercer DW, Cross JM, Castaneda AA, Gunter JA. Gastroprotective actions of bombesin, L-DOPA, and mild irritants: Roles of prostaglandins and sensory neurons. Surgery 124:864-870, 1998.
38. Thun MJ. Aspirin, NSAIDs, and digestive tract cancers. Cancer Metastasis Rev 13:269-277, 1994.
39. Baron JA, Sandler RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 51:511-523, 2000.
40. Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci 30:3-21, 2000.
41. Blanco FJ, Guitian R, Moreno J, de Toro FJ, Galdo F. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J Rheumatol 26:1366-1373, 1999.
42. Kato M, Nishida S, Kitasato H, Sakata N, Kawai S. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: Investigation using human peripheral monocytes. J Pharm Pharmacol 53:1679-1685, 2001.
43. Kawai S, Nishida S, Kato M, Furumaya Y, Okamoto R, Koshino T, Mizushima Y. Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. Eur J Pharmacol 347:87-94, 1998.